---  
layout: startup_page  
title: "PRISM BioLab"  
id: "prismbiolab.com"  
permalink: "/prismbiolabprismbiolab.com01242024/"  
website: "https://www.prismbiolab.com/"  
funding_round: ""  
funding_amount: "$10.3M"  
investors: "Eli Lilly and Company, Santec Holdings Corporation"  
about: "PRISM BioLab is a biotechnology company focused on discovering small molecule inhibitors of protein-protein interaction (PPI) targets. They utilize their proprietary PepMetics technology to create orally available drugs for various diseases, including cancer and autoimmune disorders. This technology addresses the challenge of targeting PPIs, previously considered 'undruggable', by mimicking crucial peptide structures."  
markets: "Biotechnology, Pharmaceuticals, Drug Discovery"  
hq: "Tokyo, Tokyo, Japan"  
founded_year: "2006"  
linkedin: "https://www.linkedin.com/company/prismbiolab-co-ltd"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/prism-biolab"  
pitchbook: "https://pitchbook.com/profiles/company/57510-28"  

date_display: "24-Jan-2024"  
date: "2024-01-24"

# SEO Optimization  
meta_title: "PRISM BioLab -  Funding ($10.3M)"  
meta_description: "PRISM BioLab, PRISM BioLab is a biotechnology company focused on discovering small molecule inhibitors of protein-protein interaction (PPI) targets. They utilize th..."  
meta_keywords: "PRISM BioLab, Biotechnology, Pharmaceuticals, Drug Discovery,  funding"  
canonical_url: "https://startup.projectstartups.com/prismbiolabprismbiolab.com01242024/"  
---